0000950170-24-074873.txt : 20240618
0000950170-24-074873.hdr.sgml : 20240618
20240618161605
ACCESSION NUMBER: 0000950170-24-074873
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240617
FILED AS OF DATE: 20240618
DATE AS OF CHANGE: 20240618
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lloyd Marcea Bland
CENTRAL INDEX KEY: 0001389208
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39376
FILM NUMBER: 241051993
MAIL ADDRESS:
STREET 1: 9360 TOWNE CENTRE DRIVE
STREET 2: SUITE 110
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Poseida Therapeutics, Inc.
CENTRAL INDEX KEY: 0001661460
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 472846548
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9390 TOWNE CENTRE DRIVE
STREET 2: SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-779-3100
MAIL ADDRESS:
STREET 1: 9390 TOWNE CENTRE DRIVE
STREET 2: SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
ownership.xml
4
X0508
4
2024-06-17
false
0001661460
Poseida Therapeutics, Inc.
PSTX
0001389208
Lloyd Marcea Bland
C/O POSEIDA THERAPEUTICS, INC.
9390 TOWNE CENTER DRIVE SUITE 200
SAN DIEGO
CA
92121
true
false
false
false
false
Common Stock
2024-06-17
4
A
false
19650
0.00
A
68950
D
Stock Option (Right to buy)
2.81
2024-06-17
4
A
false
27350
0.00
A
2034-06-16
Common Stock
27350
27350
D
Represents restricted stock units granted pursuant to the Issuer's Equity Incentive Plan. The RSUs are scheduled to vest on the earlier to occur of (i) the one year anniversary of the date of grant and (ii) the day preceding the date of the next annual meeting of the Issuer's stockholders.
The stock option will vest and become fully exercisable on the earlier to occur of (i) the one year anniversary of the date of grant and (ii) the day preceding the date of the next annual meeting of the Issuer's stockholders.
/s/ Harry J.Leonhardt, Attorney-in-Fact
2024-06-18